Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (9004)	3/8/1999 6:22:00 PM
From: opalapril	Read Replies (1) \| Respond to of 17367

Blue: I saw Rocketman's reply to your inquiry. Clever, about points for diving difficulty.

To: Bluegreen who wrote (9004)	3/8/1999 6:37:00 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

Hey Bob, did you see where Joltin Joe passed away? What a team they must have up there now! Bob?

To: Bluegreen who wrote (9004)	3/9/1999 10:12:00 AM
From: Chris Boylan	Read Replies (3) \| Respond to of 17367

> It might interest you to know that historically speaking, > administering Neuprex in Meningo. INCREASES morbidity. I meant mortality not morbidity. My post would have seemed non-sensical if I meant morbidity. This little sentence of yours only makes sense if you are referring to the fact that when you have fewer dead people you have more sick people. If you meant something else then I'd appreciate it if you would follow up because I can't imagine what it would be. > Hard to see how you can be long using your posts as a guide. > It looks as though you just jumped in with some off the cuff > ramblings. Oh hush. If I jump in with some off the cuff ramblings you'll know because I'll be talking about something totally irrelevant, like dead baseball players.